Alexandria Venture Investments
About Alexandria Venture Investments
Alexandria Venture Investments is a venture capital firm that develops the work in real estate technology, and healthcare sectors.
Investment focus
Sectors
Portfolio (35 in our database)
KallyopeKallyope is a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis.Series D · $479M raisedElement BiosciencesElement Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.Series C · $401M raisedInariInari presents high performing plant varieties that improve the economic and environmental realities of production agriculture.Series D · $382M raisedHalioHalio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.Series D · $329M raisedVentus TherapeuticsVentus Therapeutics develops small molecule medicines that target innate immune protein structures.Series C · $300M raisedDewpoint TherapeuticsDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.Series C · $287M raisedEGenesisEGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.Series C · $265M raisedEncoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.Series D · $239M raisedMOMA TherapeuticsMOMA Therapeutics operates as a biotechnology company.Series B · $236M raisedAspen NeuroscienceAspen Neuroscience is a biotechnology company that uses innovative genomic approaches combined with stem cell biology.Series B · $224M raisedKorro BioKorro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.Series B · $208M raisedEpic SciencesEpic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.Series F · $196M raisedAmbys MedicinesAmbys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.Series A · $187M raisedWugenWugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignanciesSeries B · $172M raisedAffinia TherapeuticsAffinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.Series B · $170M raisedObsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.Series B · $165M raisedAsher BioAsher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.Series B · $163M raisedBoundless BioBoundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.Series B · $151M raisedRemix TherapeuticsRemix Therapeutics is a biotechnology company.Series B · $151M raisedCelsius TherapeuticsCelsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.Series B · $148M raisedBioTheryXBioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.Series E · $147M raisedCibusCibus specializes in developing plant and microbial platforms .Acquired · $131M raisedVariant BioVariant Bio is leveraging the power of human genetic diversity to discover new therapeutics.Series B · $130M raisedAcrivon TherapeuticsAcrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.Series B · $116M raisedAdaptive Phage TherapeuticsAdaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.Series B · $115M raisedArrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.Series B · $113M raisedStrideBioStrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.Series B · $97M raisedMolecular AssembliesMolecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.Series B · $87M raisedTerray TherapeuticsTerray Therapeutics is a biotechnology company.Series A · $80M raisedGNS HealthcareGNS Healthcare is a big data analytics company focuses on discovering what works in the healthcare industry and for whom.Series D · $77M raisedEncodiaEncodia is a biotech company that develops the next generation of protein analysis tools.Series C · $75M raisedTwinStrand BiosciencesTwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.Series B · $73M raisedQurAlisQurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for ALS.Series A · $48M raisedKytopenKytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.Series A · $37M raisedPlenoPleno is a multi-omic instrument platform company democratizing biological target detection for clinical testing.Seed · $15M raised